BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,478,000 | -34.1% | 92,498 | -46.4% | 0.17% | -24.2% |
| Q1 2022 | $20,453,000 | -30.2% | 172,498 | -18.8% | 0.22% | -19.2% |
| Q4 2021 | $29,284,000 | -9.3% | 212,498 | -8.6% | 0.28% | -16.6% |
| Q3 2021 | $32,296,000 | +34.4% | 232,498 | -6.1% | 0.33% | +33.5% |
| Q2 2021 | $24,027,000 | +42.0% | 247,498 | 0.0% | 0.25% | +49.4% |
| Q1 2021 | $16,916,000 | +5.3% | 247,498 | +32.0% | 0.17% | +3.1% |
| Q4 2020 | $16,070,000 | -1.8% | 187,498 | -25.5% | 0.16% | -12.5% |
| Q3 2020 | $16,366,000 | +11.0% | 251,751 | +24.8% | 0.18% | +7.0% |
| Q2 2020 | $14,750,000 | +39.0% | 201,751 | -35.3% | 0.17% | +16.2% |
| Q1 2020 | $10,609,000 | -37.5% | 311,751 | 0.0% | 0.15% | -27.1% |
| Q4 2019 | $16,972,000 | +30.5% | 311,751 | 0.0% | 0.20% | +23.0% |
| Q3 2019 | $13,006,000 | -4.7% | 311,751 | 0.0% | 0.16% | -2.9% |
| Q2 2019 | $13,652,000 | -30.5% | 311,751 | -18.3% | 0.17% | -31.7% |
| Q1 2019 | $19,649,000 | +77.9% | 381,751 | +27.8% | 0.25% | +55.6% |
| Q4 2018 | $11,048,000 | – | 298,750 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |